Skip to main content

Table 1 Child demographics

From: Sankofa pediatric HIV disclosure intervention did not worsen depression scores in children living with HIV and their caregivers in Ghana

 

Disclosure Status

 

No (N = 35)

Yes (N = 122)

Total (N = 157)

p Value

Gender

 Female

019 (54.29%)

060 (49.18%)

079 (50.32%)

 

 Male

016 (45.71%)

062 (50.82%)

078 (49.68%)

0.59 a

Child Age

 Mean (95% CL)

8.88 (8.25–9.51)

10.31 (9.86–10.75)

9.99 (9.61–10.37)

< 0.001c, ***

 Median (IQR)

9 (7–10)

10 (8–12)

10 (8–12)

 

 N (N Missing)

33 (2)

118 (4)

151 (6)

 

School

 Yes

030 (85.71%)

116 (95.08%)

146 (92.99%)

 

 No

002 (5.71%)

001 (0.82%)

003 (1.91%)

 

 Patient refused to answer

000 (0.00%)

001 (0.82%)

001 (0.64%)

 

 Missing

003 (8.57%)

004 (3.28%)

007 (4.46%)

0.20 b

HIV Transmission Mode

 MTC

025 (71.43%)

100 (81.97%)

125 (79.62%)

 

 Other

001 (2.86%)

003 (2.46%)

004 (2.55%)

 

 Missing

009 (25.71%)

019 (15.57%)

028 (17.83%)

1.00 b

Duration of HIV (days)

 Mean (95% CL)

1503.60 (1006.07–2001.13)

1749.07 (1545.42–1952.71)

1702.58 (1514.83–1890.32)

0.31 c

 Median (IQR)

1264 (406–2513)

1928 (747–2588)

1898 (745–2579)

 

 N (N Missing)

25 (10)

107 (15)

132 (25)

 

Duration of ART treatment (days)

 Mean (95% CL)

804.92 (381.21–1228.64)

1355.88 (1162.56–1549.19)

1246.53 (1068.69–1424.37)

0.014 c, *

 Median (IQR)

350 (32–1208)

1389 (406–2145)

1281 (147–2107)

 

 N (N Missing)

26 (9)

105 (17)

131 (26)

 

WHO Staging at time of Diagnosis

 Stage 1

003 (8.57%)

016 (13.11%)

019 (12.10%)

 

 Stage 2

006 (17.14%)

044 (36.07%)

050 (31.85%)

 

 Stage 3

014 (40.00%)

030 (24.59%)

044 (28.03%)

 

 Stage 4

002 (5.71%)

013 (10.66%)

015 (9.55%)

 

 Missing

010 (28.57%)

019 (15.57%)

029 (18.47%)

0.10 a

HIV+ caregiver

 Yes

017 (48.57%)

079 (64.75%)

096 (61.15%)

 

 No or Unsure

017 (48.57%)

040 (32.79%)

057 (36.31%)

 

 Missing

001 (2.86%)

003 (2.46%)

004 (2.55%)

0.08 a

Does anyone help you take your medicine?

 Yes

024 (68.57%)

101 (82.79%)

125 (79.62%)

 

 No

006 (17.14%)

012 (9.84%)

018 (11.46%)

 

 Missing

005 (14.29%)

009 (7.38%)

014 (8.92%)

0.21 a

Who helps you with your medicine most of the time?

 Biological parent (Mother/Father)

017 (48.57%)

075 (61.48%)

092 (58.60%)

 

 Family (Grandparent/Aunt/Uncle)

006 (17.14%)

013 (10.66%)

019 (12.10%)

 

 Other family member

001 (2.86%)

010 (8.20%)

011 (7.01%)

 

 Other

000 (0.00%)

002 (1.64%)

002 (1.27%)

 

 Unknown

000 (0.00%)

001 (0.82%)

001 (0.64%)

 

 Missing

011 (31.43%)

021 (17.21%)

032 (20.38%)

0.55 b

Days since disclosure

 Mean (95% CL)

NA (NA – NA)

1540.62 (1467.34–1613.90)

1540.62 (1467.34–1613.90)

 

 Median (IQR)

NA (NA – NA)

1573 (1215–1834)

1573 (1215–1834)

 

 N (N Missing)

0 (35)

121 (1)

121 (36)

 

Days since enrollment

 Mean (95% CL)

1603.26 (1461.08–1745.43)

1914.43 (1851.38–1977.48)

1845.06 (1783.96–1906.15)

< 0.001c, ***

 Median (IQR)

1519 (1238–1921)

1941 (1624–2243)

1893 (1519–2215)

 
  1. Legend: * p < 0.05, *** p < 0.001
  2. a Chi-square test, b Fisher’s Exact test, c T test
  3. Abbreviations: ART antiretroviral therapy; CL confidence level; IQR interquartile range; MTC mother-to-child